Cartalax is a synthetic tripeptide, Ala-Glu-Asp (AED), also catalogued as T-31, and it falls in the Khavinson family of peptides. The same model applies here as with everything else in the Khavinson program: first analyze the peptide composition of an organ's tissue extract, then find
For years, the single most accurate thing anyone could say about BPC-157 was this: the mechanism data is extensive, the animal evidence is broad and consistent, and the human evidence is almost nonexistent. That's what makes a new entry on ClinicalTrials.gov worth looking at. A trial
Six weeks ago we published a detailed breakdown of what the July PCAC vote actually meant and, more importantly, what it didn't. The short version: six peptides received favorable advisory recommendations, nothing became legal to compound overnight, and a wave of "FDA-approved!" marketing began circulating
Most peptides are in a gray zone. They're interesting, but have little human data, no regulatory approval. Every so often, though, a peptide shows up in a top-tier medical journal with a properly designed human trial behind it. Kisspeptin is one of those, and a study published
On July 23 and 24, 2026, at the FDA's White Oak campus, something happened that reporters in the room described as causing an audible gasp: an FDA advisory committee publicly overruled the agency's own scientists. Then it did it five more times. By the end of
Telomerase is not an unambiguously good thing to switch on. This same enzyme that could theoretically slow cellular aging is the enzyme that roughly 85–90% of cancers reactivate to become immortal.
You've seen the post. "My go-to stack..." Someone with a ripped physique tells you that if you want to be like them here's a discount code. Maybe it's a recovery stack, or longevity protocol, or it might be whatever the algorithm
Retatrutide — sometimes called Reta or GLP-3, is the latest weight loss peptide. This post is a primer for someone who's heard the name and wants to understand what it actually is, how it differs from the GLP-1 medications already available, what the latest clinical trial data
Melanotan is one of the more recognizable peptide names, mostly because of its association with sunless tanning. What's less well known is that "Melanotan" actually refers to two distinct compounds with genuinely different safety profiles and entirely different regulatory fates, and that the research behind both
One of the raging debates about peptides, and one of the hardest to answer well — is deceptively simple: how long should I use this? The answer is, it depends on which compound you're talking about. "How long should I take BPC-157 daily?" and "how
Wait, could this help my dog? This post is a guide to help you get oriented to peptides & pets. You'll learn where things stand, and what the actual options are depending on what your pet's dealing with. First: Your Pet Is Already Getting Peptides Before
If you've been following the peptides for more than a year, you've heard some version of this story: the FDA cracked down on BPC-157 and TB-500 in 2023, and now things might be changing. What that story usually lacks is the regulatory mechanism — how